puva therapy decreases hla-dr+ cdia+ langerhans cells and epidermal cell antigen-presenting capacity in human skin , but flow cytometrically-sorted residual hla-dr+ cdia+ langerhans cells exhibit normal alloantigen-presenting function .
C0086418
human
C0019764
hla-dr